News
SNYNF
83.60
NaN%
--
Sanofi Updates Infant Pompe Disease Study: What Investors Should Know
TipRanks · 15h ago
Sanofi's Biggest Moneymaker to Face Competition -- Market Talk
Dow Jones · 1d ago
Windward Bio Group IPO of 10.3M Shrs Prices at $17 Each
Dow Jones · 1d ago
Sanofi Discloses October 31, 2026 Share and Voting Rights Figures
TipRanks · 1d ago
Sanofi Updates Fabry Disease Study: What Investors Should Know
TipRanks · 1d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Compass Therapeutics (CMPX), Innate Pharma (IPHA) and Sanofi (OtherSNYNF)
TipRanks · 4d ago
Sanofi upgraded to Outperform from Neutral at BNP Paribas
TipRanks · 4d ago
Weekly Report: what happened at SNYNF last week (1102-1106)?
Weekly Report · 4d ago
69 Dividend Champions Ranked By Quality Scores (November 2026)
Seeking Alpha · 6d ago
Midday Fly By: Democrats win major victories, AMD reports upbeat Q3
TipRanks · 11/04 17:11
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Amgen (AMGN)
TipRanks · 11/04 14:10
Bernstein Sticks to Their Buy Rating for Sanofi (SNYNF)
TipRanks · 11/04 14:09
Nurix falls as Sanofi scraps inflammatory disease drug
Seeking Alpha · 11/04 12:26
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Sanofi (OtherSNYNF)
TipRanks · 11/04 10:30
Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX) and Sanofi (OtherSNYNF)
TipRanks · 11/04 07:50
Nurix Therapeutics Shares Plunge on Sanofi's Termination of Drug Development Program
Dow Jones · 11/03 21:56
Sanofi price target raised to EUR 86 from EUR 82 at Morgan Stanley
TipRanks · 11/03 19:20
Regeneron and Sanofi Update Long-Term Pediatric Dupixent Study
TipRanks · 11/03 16:30
Sanofi price target raised to EUR 90 from EUR 83 at Barclays
TipRanks · 11/02 17:11
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Agios Pharma (AGIO) and Abbott Laboratories (ABT)
TipRanks · 11/02 15:30
More
Webull provides a variety of real-time SNYNF stock news. You can receive the latest news about Sanofi FR through multiple platforms. This information may help you make smarter investment decisions.
About SNYNF
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.